Cohen Jeffrey,...,Stojanovic Miroslav,...,(broj koautora 18) (2012) Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial, LANCET, vol. 380, br. 9856, str. 1819-1828 (Article)